Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025
Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025 Meeting Regulator Expectations for Decentralized and Hybrid Trials The Compliance Frame: What “Good” Looks Like for DCTs Regulators evaluate decentralized and hybrid trials against a simple standard: the same scientific validity, participant protection, and data integrity expected at an on-site visit must be demonstrated when…
Read More “Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025” »